Stock Information
Terns Pharmaceuticals Inc (TERN)
Ticker Symbol: TERN
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $4,749.01 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -1.0338
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -20.02%
Latest News
-
Oppenheimer Downgrades Terns Pharmaceuticals to Perform, Removes Price Target $58
Mon, Apr 27, 2026 10:00 AM
-
Merck: Bullish Setup Into Q1 Earnings
Mon, Apr 27, 2026 8:39 AM
-
Terns Pharmaceuticals Wins FDA Breakthrough Therapy Designation For TERN-701 In Resistant CML
Mon, Apr 27, 2026 8:13 AM
-
Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia
Mon, Apr 27, 2026 8:05 AM
Key Financials
Financial data not available
